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Objectives: The severity of pre-existing pathological changes in human saphenous vein (HSV) correlates with the 
development of vein graft stenosis and graft patency. The aim of this study was to investigate the influence of pre-existing 
intimal hyperplasia on development of the neointima in vitro, using an organ culture model. 
Materials and Methods: Segments of HSV were harvested uring coronary artery bypass surgery. Histology was 
performed on part of the vein; the remainder was maintained in culture. Pre-existing intimal thickness (PIT) in HSV 
from day 0 and neointimal thickness (NIT) in cultured HSV were measured using computerised image analysis on 
histological sections. Day 0 and 14 veins were compared with respect o intimal hyperplasia. 
Results: Twelve pairs of veins were examined. A mean tissue ATP of 297 nmoles/g wet weight for cultured HSV 
confirmed cell viability. Mean PIT was 180 #m (CI:86-274) and mean NIT was 60 l~m (CI:48-72), with a significant 
correlation between them using the Spearman Rank test (Rs = 0.72; p = 0.008). 
Conclusions: Pre-existing vein quality as measured by PIT correlates with the development of neointimal hyperplasia 
in culture, adding further support o clinical evidence that poor vein quality predisposes to vein graft stenosis due to an 
inherent susceptibility to intimal hyperplasia. 
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Introduction 
Autogenous saphenous vein is regarded as the conduit 
of choice for bypass grafting, but 20-30% of grafts 
fail during the first 12 months postoperatively. 1 The 
majority of these failures are due to progressive sten- 
oses caused by the process of neointimal hyperplasia, 
which is characterised by a proliferation of smooth 
muscle cells. ~ The precise aetiology of intimal hy- 
perplasia remains unclear. What is clear, however, 
is that graft patency rates are influenced by patient 
selection, surgical technique and the intrinsic quality 
of the conduit and it may be that pre-existing mor- 
phological variations both within and between veins 
are responsible for at least some of the lesions ob- 
served. 
Over the last two decades, several morphological 
studies have noted the presence of pre-existing patho- 
logical changes in human saphenous vein (HSV) (Fig. 
1) 5 10 More recently, the severity of these pre-existing 
* Please address all correspondence to: Miss Y. G. Wilson, Vascular 
Studies Unit, Level 7, Bristol Royal Infirmary, Bristol, U.K. 
changes have been linked with the development of
vein graft stenosis and graft patency. 1°-13 , 
Organ culture of HSV provides an ideal method for 
further studying the effects of intrinsic change on 
the aetiology of intimal hyperplasia. The technique 
represents an established model of intimal hy- 
perplasia. 14-16 Smooth muscle cells in the media pro- 
liferate and migrate sub-endothelially to produce a 
neointimal layer which is morphologically similar to 
that described by Sottiurai et al. in human vein grafts 
(Fig. 2). 17 The advantages of the organ culture model 
are that the vein is kept in controlled and reproducible 
conditions and, unlike cell culture, the whole vein 
is preserved, thus maintaining normal vessel wall 
architecture and intercellular relationships. It is ap- 
preciated, however, that the model has its limitations 
and that the stimuli for intimal hyperplasia in vitro 
are likely to differ from those present in vivo. Most 
obvious is the absence of flow, which has been shown 
to be influential in vivo. 
The aim of this study was to investigate he influence 
of pre-existing-vein quality, as determined by pre- 
existing intimal thickness on development of the neo- 
intima in vitro. 
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Fig. 1. Histological sections illustrating pre-existing intimal changes. 
(a) Normal vein (EVG x 50). (b) Vein with marked pre-existing 
intimal hyperplasia (EVG x 50). (c) Eccentric plaque of pre-existing 
intimal hyperplasia (EVG x 50). (IEL = internal elastic lamina; IH = 
intimal hyperplasia; MH=muscle hypertrophy). Reproduced here 
at 55%. 
Mater ia l s  and Methods  
Segments of long saphenous vein (2-3 cm lengths) 
were harvested fresh from 12 patients undergoing 
coronary artery surgery using an atraumatic, no touch 
technique. In practice, vein was harvested at the level 
of the proximal extent of the dissection, usually mid- 
thigh level. 
Fig. 2. Histological sections showing neo-intimal hyperplasia (NIH) 
in cultured HSV. (a) EVG (x 200). (b) Smooth muscle ll actin 
( x 400). The immunohistochemical marker confirms that the cellular 
element of the neointimal layer is comprised of SMCs. Reproduced 
here at 55%. 
The veins were processed according to the method 
of Pederson and Bowyer, later modified by Soyombo 
et a1.14"15 The fresh vein was transported in sterile RPMI 
1640 tissue culture medium (Gibco Life Technologies 
Ltd., Paisley, U.K.) at 37°C, containing 20mmol/1 
Hepes buffer, sodium heparin (Leo Laboratories, 
Princes Risborough, U.K.), papaverine (South Devon 
Healthcare Trust, Torbay, U.K.) and amphotericin (ICN 
Biomedicals Ltd., Thame, U.K.) and processed in the 
sterile conditions of the flow cabinet (Class II micro- 
biological safety cabinet, conforming to BS5726; Safety 
Cabinets Ltd., Glossop, U.K.). Using aseptic technique, 
the adventitia was carefully stripped from each vein 
whilst in a sterile washing medium consisting of RPMI 
1640 medium containing Hepes buffer, gentamicin 
(80mg/ml) (Roussel, Uxbridge, U.K.), penicillin 
(5000 iu/ml), streptomycin (5000 btg/ml) (Leo Laborat- 
ories) and L-glutamine (Gibco) (2mmol/1) at 37°C. 
Each vein was then opened longitudinally using mi- 
croscissors and discarding the potentially damaged 
ends, and divided transversely into 0.5-1 cm 2 segments 
using a sterile scalpel blade. 
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Fig. 3. Schematic diagram, showing the allocation and processing of vein for organ culture. 
Where possible, four segments were obtained from 
each vein harvested (Fig. 3). One segment was snap- 
frozen in liquid nitrogen and kept for subsequent assay 
of adenosine triphosphate (ATP) to confirm tissue 
viability prior to culture. A second segment was fixed 
in 10% formal saline and sent for staining and light 
microscopy to measure pre-existing intimal thickness 
(PIT) prior to culture as a representation f vein quality. 
The remaining two segments were submitted to organ 
culture. 
Vein for culture was transferred with sterile mi- 
croforceps, endothelium uppermost, into sterile Petri 
dishes containing set Sylgard resin (Dow Corning, 
Seneffe, Belgium) and sterile washing medium and 
pinned out on polyester mesh (500 ~tm) using minuten 
pins (size A1, Watkins and Doncaster, Kent, U.K.). 
After two or three washings, the washing medium 
was exchanged for 10 ml of culture medium: RPMI 
1640 with sodium bicarbonate (Gibco), 30% fetal calf 
serum, gentamicin, penicillin, streptomycin and L-glu- 
tamine (all as above). The vein was incubated at 37 °C 
in humidified 5% CO2 for 14 days with change of the 
medium every 48-72h. At the end of the culture 
period, the segments were washed with Dulbecco's 
phosphate buffered saline and one was again snap- 
frozen in liquid nitrogen and stored for subsequent 
assay of ATP, and the other was sent for microscopy 
to measure neointimal thickness (NIT) post-culture. 
Light microscopy 
Formalin-fixed vein segments from both days 0 and 
14 of the culture period were dehydrated with a graded 
alcohol series from 70% to absolute alcohol over 24 h, 
before being cleared and embedded in paraffin wax 
for serial sectioning. Five ~tm sections were stained 
with Harris' haematoxylin and eosin (H&E) and Mill- 
er's elastic van Gieson (EVG), respectively. Sections 
were examined at light microscopy (Carl Zeiss, West 
Germany), using a computerised windows-based 
image analyser package (Microscale, Digithurst Ltd., 
Royston, Herts., U.K.) to measure both PIT in pre- 
cultured veins and NIT in post-cultured veins for a 
comparative study of the influence of pre-existing 
intimal hyperplasia on the development of the neo- 
intima following harvesting and culture (Fig. 4). The 
entire length of the section was examined in con- 
secutive fields, and five measurements were obtained 
per field. The mean of these measurements denoted 
the intimal thickness for the section. 
Measurement ofadenosine triphosphate 
Adenosine triphosphate was extracted from stored, 
frozen vein according to the methods of Willamson 
and Corkey and Angelini et al., which have been shown 
to effectively extract adenosine nucleotides from tis- 
sues without causing their degradation. 18'19 ATP was 
extracted using ice-cold 5% perchloric acid, which was 
then neutralised by an equal volume of 0.5M tri-n- 
octylamine in 1,1,2 trichlorofluoroethane (Freon), 
which formed a bi-layer, with the aqueous phase 
uppermost. 2° 
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Fig. 4. Measurement of intimal thickness. (a) PIT in a vein section 
pre-culture (EVG x 200). (b) NIT in a vein section post-culture 
(EVG x 200). Reproduced here at 55%. 
Once isolated in the aqueous layer, the ATP con- 
centration was measured using luminometry (Bio- 
Orbit 1250 luminometer) according to the firefly bio- 
luminescence assay for ATP, which is based on the 
quantitative measurement of light emission. 21'= Results 
were expressed as ATP concentration in nmoles/g wet 
weight of tissue. 
Statistical analysis 
Pre- and post-cultured veins were compared using the 
Spearman Rank test. Results were expressed as means 
with 95% confidence intervals. 
Results 
Twelve pairs of veins (pre- and post-culture) were 
examined. ATP measurement by luminometric assay 
in freshly harvested and cultured vein confirmed cell 
Table 1. Tissue v/ability (ATP) and comparison of pre-existing 
and neointimal thickness in pre- and post-cultured vein (data 
expressed as means with 95% confidence intervals in parentheses). 
n=12 
ATP 
(nmoles/g wet Intimal thickness 
weight) (pm) 
Pre-culture 254 PIT 
(181-327) "180 (86-274) 
Post-culture 297 NIT 
(240-355) *60(48-72) 
* Spearman Rank correlation coefficient (R~ =0.72; p=0.008). 
viability (Table 1). Figure 4 demonstrates measurement 
of PIT and NIT in two vein sections. Mean PIT and NIT 
values are shown in Table 1. There was a significant 
correlation between PIT and NIT using the Spearman 
Rank test (Rs=0.72; p=0.008). 
Discussion 
During the last 20 years, morphological studies of the 
long saphenous vein have demonstrated a spectrum 
of anatomical variation and pathological change. >11 
The majority of earlier studies concentrated on the 
appearances of vein after arterialisation and/or graft 
failure, using material harvested at autopsy or at redo 
surgery, often following coronary artery bypass. 6'a3-27 
The assumption was that the lesions observed were 
acquired after implantation as a result of various tim- 
uli acting on damaged endothelium. The discovery of 
pre-existing changes, which in addition td intimal 
thickening (Fig. 1) include variable degrees of Smooth 
muscle hypertrophy and inflammatory cell infiltration, 28 
implies an inherent predisposition to subsequent 
thrombosis on abnormal luminal surfaces and to sten- 
osis and/or occlusion through further progression of 
hyperplastic change. More recently, these anomalies 
have indeed been linked to graft patency following 
peripheral bypass. I1'12'28'29 
Waller and Roberts examined a total of 3394 cm of 
unused vein from 402 patients undergoing coronary 
artery grafting and identified variable degrees of lu- 
minal narrowing due to pre-existing fibrous thick- 
ening. 7Histologically, intimal hyperplasia ccounted 
for most of the thickening and was not dissimilar to the 
microscopic appearances of the hyperplastic lesions 
causing focal vein graft stenoses post-implantation 
(Fig. 1). 3° The incidence of the pre-existing changes 
was independent of age and sex, and severity varied 
both within and between veins. Davies et al. fotmd 
changes to be more frequent and more severe in distal 
veins. ~° 
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There is a wide variation between published reports 
with regard to the incidence of pre-existing ab- 
normality. Cheanvechai et al. noted abnormalities in
27% of vein remnants at coronary artery bypass, al- 
though subsequent coronary arteriography revealed 
no difference between ormal and diseased veins with 
regards to patency at 2 years. 5Thiene et al. found some 
degree of fibrous intimal/media thickening in 93% of 
veins, but it was rarely severe nough to compromise 
the lumen. 31 Scott et al. and Milroy et al. examined 
unused vein from patients undergoing femorodistal 
bypass and, finding abnormalities (intimal hyperplasia 
and muscle hypertrophy) in all the vein remnants, 
suggested that such features might influence graft 
outcome.9'32 
Previous work from this unit has shown that veins 
with moderate and severe pre-existing disease are less 
compliant. 33The resulting compliance mismatch may 
produce flow disturbance and predispose to graft fail- 
ure. Davies also reported accumulations of macro- 
phages and lymphocytes in vein walls prior to bypass, 
and there was a significant association between the 
severity of the infiltration and vein graft stenosis. 
Brody et al. detected the cytokine, interleukin-l~ (IL- 
1~), in the media of veins with histological ab- 
normalities prior to surgery and in failed saphenous 
vein grafts following coronary artery bypass. The inter- 
leukin was not detected in normal veins pre-bypass. 
As IL-la has the ability to activate endothelial cells 
in a prothrombotic manner and to stimulate smooth 
muscle cells and fibroblasts, they suggested that its 
presence in abnormal veins might predispose them to 
the myointimal proliferation that leads to luminal 
narrowing and, ultimately, occlusion. 
Pre-existing vein quality, designated by PIT in this 
study, correlates with the development of neointimal 
hyperplasia in culture. Whilst appreciating that direct 
extrapolation tothe clinical situation requires caution, 
these findings add further support o clinical evidence 
that poor vein quality predisposes tovein graft stenosis 
by stimulating rowth of the neointima. The logical 
extension to this work is to relate neointimal growth 
in veins harvested from patients undergoing infra- 
inguinal bypass to the development of intimal hy- 
perplasia in vivo. These patients are routinely recruited 
to the duplex graft surveillance programme and the 
detection of a stenosis would herald development of
intimal hyperplasia. If a close correlation were found 
between intimal responses in vitro and in vivo then, 
after only 14 days of organ culture, it might be possible 
to predict which patients could anticipate graft prob- 
lems, and such patients could be followed up more 
intensively. At the other end of the spectrum, patients 
with minimal neointimal growth in culture might need 
less intensive surveillance. 
Whilst further emphasising the importance of vein 
quality, this study does not provide an explanation 
with regards to the focal nature of vein graft stenoses. 
However, it could be postulated that pre-existing, 
hyperplastic lesions or other focal, intra-luminal ab- 
normalities at the time of implantation and in the 
presence of intrinsically poor vein are the basis of 
definitive stenoses. It is possible to detect such lesions 
macroscopically using angioscopyY These could be 
biopsied and maintained in culture alongside control 
segments from the same vein, providing acomparative 
assessment of neointimal growth according to pre- 
existing morphology. 
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